AMICUS THERAPEUTICS, INC. 8-K

What Happened

• Amicus Therapeutics, Inc. (FOLD) announced its financial results for the fiscal year ended December 31, 2025 by issuing a press release on February 20, 2026. The company filed a Current Report on Form 8-K (Item 2.02) to disclose the press release, which is attached as Exhibit 99.1.

Key Details

• Filing date: February 20, 2026 (Form 8-K reporting Item 2.02: Results of Operations and Financial Condition).
• Reporting period: Fiscal year ended December 31, 2025.
• Disclosure: Press release announcing the results attached as Exhibit 99.1 and an Inline XBRL cover page included as Exhibit 104.
• Legal note: Per General Instruction B.2. of Form 8-K, the information and exhibits are furnished (not “filed”) for purposes of Section 18 of the Exchange Act and are not automatically incorporated by reference into other filings.

Why It Matters

• This filing signals that full-year 2025 financial results are now publicly available; those results (revenue, earnings, cash position, guidance) are contained in the attached press release and are material for investors evaluating Amicus’s recent performance and outlook.
• Investors should review Exhibit 99.1 (the press release) for the specific financial figures, any management commentary, and any guidance or forward-looking statements that could affect the company’s stock and investment decisions.